Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III.

Simpson KN, Simpson AN, Mauldin PD, Palesch YY, Yeatts SD, Kleindorfer D, Tomsick TA, Foster LD, Demchuk AM, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Broderick JP; Interventional Management of Stroke (IMS) III Investigators.

J Am Heart Assoc. 2017 May 8;6(5). pii: e004513. doi: 10.1161/JAHA.116.004513.

2.

Reply.

Tomsick TA, Liebeskind DS, Hill MD, von Kummer R, Goyal M, Broderick JP.

AJNR Am J Neuroradiol. 2017 Jun;38(6):E44-E45. doi: 10.3174/ajnr.A5200. Epub 2017 May 4. No abstract available.

3.

Fluid-Signal Structures in the Cervical Spinal Cord on MRI: Anterior Median Fissure versus Central Canal.

Tomsick TA, Peak E, Wang L.

AJNR Am J Neuroradiol. 2017 Apr;38(4):840-845. doi: 10.3174/ajnr.A5121. Epub 2017 Mar 9.

4.

Severe carotid stenosis and delay of reperfusion in endovascular stroke treatment: an Interventional Management of Stroke-III study.

Gogela SL, Gozal YM, Zhang B, Tomsick TA, Ringer AJ, Broderick JP, Khatri P, Abruzzo TA.

J Neurosurg. 2018 Jan;128(1):94-99. doi: 10.3171/2016.9.JNS161044. Epub 2017 Feb 3.

PMID:
28156253
5.

Recanalization and Angiographic Reperfusion Are Both Associated with a Favorable Clinical Outcome in the IMS III Trial.

Schmitz ML, Yeatts SD, Tomsick TA, Liebeskind DS, Vagal A, Broderick JP, Khatri P.

Interv Neurol. 2016 Sep;5(3-4):118-122. Epub 2016 Jun 16.

6.

Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes.

Tomsick TA, Carrozzella J, Foster L, Hill MD, von Kummer R, Goyal M, Demchuk AM, Khatri P, Palesch Y, Broderick JP, Yeatts SD, Liebeskind DS; IMS III Investigators.

AJNR Am J Neuroradiol. 2017 Jan;38(1):84-89. doi: 10.3174/ajnr.A4979. Epub 2016 Oct 20.

7.

Multimodal CT Imaging: Time to Treatment and Outcomes in the IMS III Trial.

Vagal A, Foster LD, Menon B, Livorine A, Shi J, Qazi E, Yeatts SD, Demchuk AM, Hill MD, Tomsick TA, Goyal M.

AJNR Am J Neuroradiol. 2016 Aug;37(8):1393-8. doi: 10.3174/ajnr.A4751. Epub 2016 Mar 17.

8.

Effect of endovascular reperfusion in relation to site of arterial occlusion.

Lemmens R, Hamilton SA, Liebeskind DS, Tomsick TA, Demchuk AM, Nogueira RG, Marks MP, Jahan R, Gralla J, Yoo AJ, Yeatts SD, Palesch YY, Saver JL, Pereira VM, Broderick JP, Albers GW, Lansberg MG; DEFUSE 2, IMS III, STAR, and SWIFT trialists; DEFUSE 2 IMS III STAR and SWIFT trialists.

Neurology. 2016 Feb 23;86(8):762-70. doi: 10.1212/WNL.0000000000002399. Epub 2016 Jan 22.

9.

Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data.

Broderick JP, Berkhemer OA, Palesch YY, Dippel DW, Foster LD, Roos YB, van der Lugt A, Tomsick TA, Majoie CB, van Zwam WH, Demchuk AM, van Oostenbrugge RJ, Khatri P, Lingsma HF, Hill MD, Roozenbeek B, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson CS, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Simpson KN; IMS III Investigators; MR CLEAN Investigators.

Stroke. 2015 Dec;46(12):3416-22. doi: 10.1161/STROKEAHA.115.011397. Epub 2015 Oct 20. Erratum in: Stroke. 2016 Jan;47(1):e21. IMS II [corrected to IMS III Investigators].

10.

A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular collaboration.

MacIsaac RL, Khatri P, Bendszus M, Bracard S, Broderick J, Campbell B, Ciccone A, Dávalos A, Davis SM, Demchuk A, Diener HC, Dippel D, Donnan GA, Fiehler J, Fiorella D, Goyal M, Hacke W, Hill MD, Jahan R, Jauch E, Jovin T, Kidwell CS, Liebeskind D, Majoie CB, Martins SC, Mitchell P, Mocco J, Muir KW, Nogueira R, Saver JL, Schonewille WJ, Siddiqui AH, Thomalla G, Tomsick TA, Turk AS, White P, Zaidat O, Lees KR; VISTA Endovascular collaboration.

Int J Stroke. 2015 Oct;10 Suppl A100:136-44. doi: 10.1111/ijs.12622. Epub 2015 Sep 9.

PMID:
26352438
11.

Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial.

Tomsick TA, Foster LD, Liebeskind DS, Hill MD, Carrozella J, Goyal M, von Kummer R, Demchuk AM, Dzialowski I, Puetz V, Jovin T, Morales H, Palesch YY, Broderick J, Khatri P, Yeatts SD; IMS III Investigators.

AJNR Am J Neuroradiol. 2015 Nov;36(11):2074-81. doi: 10.3174/ajnr.A4421. Epub 2015 Jul 30.

12.

Relative Influence of Capillary Index Score, Revascularization, and Time on Stroke Outcomes From the Interventional Management of Stroke III Trial.

Al-Ali F, Elias JJ, Tomsick TA, Liebeskind DS, Broderick JP; IMS Study Groups.

Stroke. 2015 Jun;46(6):1590-4. doi: 10.1161/STROKEAHA.115.009066. Epub 2015 May 7.

13.

State of acute endovascular therapy: report from the 12th thrombolysis, thrombectomy, and acute stroke therapy conference.

Khatri P, Hacke W, Fiehler J, Saver JL, Diener HC, Bendszus M, Bracard S, Broderick J, Campbell B, Ciccone A, Dávalos A, Davis S, Demchuk AM, Dippel D, Donnan G, Fiorella D, Goyal M, Hill MD, Jauch EC, Jovin TG, Kidwell CS, Majoie C, Martins SC, Mitchell P, Mocco J, Muir K, Nogueira RG, Schonewille WJ, Siddiqui AH, Thomalla G, Tomsick TA, Turk AS, White PM, Zaidat OO, Liebeskind DS, Fulton R, Lees KR; VISTA-Endovascular Collaboration.

Stroke. 2015 Jun;46(6):1727-34. doi: 10.1161/STROKEAHA.115.008782. Epub 2015 May 5. No abstract available.

PMID:
25944325
14.

Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial.

Palesch YY, Yeatts SD, Tomsick TA, Foster LD, Demchuk AM, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Simpson A, Simpson KN, Broderick JP; Interventional Management of Stroke III Investigators.

Stroke. 2015 May;46(5):1321-7. doi: 10.1161/STROKEAHA.115.009180. Epub 2015 Apr 9.

15.

Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial.

Menon BK, Qazi E, Nambiar V, Foster LD, Yeatts SD, Liebeskind D, Jovin TG, Goyal M, Hill MD, Tomsick TA, Broderick JP, Demchuk AM; Interventional Management of Stroke III Investigators.

Stroke. 2015 May;46(5):1239-44. doi: 10.1161/STROKEAHA.115.009009. Epub 2015 Mar 19.

16.

Response.

Rahme R, Yeatts SD, Abruzzo TA, Jimenez L, Fan L, Tomsick TA, Ringer AJ, Furlan AJ, Broderick JP, Khatri P.

J Neurosurg. 2014 Dec;121(6):1352-3. No abstract available.

PMID:
25584368
17.

Time to angiographic reperfusion in acute ischemic stroke: decision analysis.

Vagal AS, Khatri P, Broderick JP, Tomsick TA, Yeatts SD, Eckman MH.

Stroke. 2014 Dec;45(12):3625-30. doi: 10.1161/STROKEAHA.114.007188. Epub 2014 Oct 28.

PMID:
25352484
18.

Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions.

Tomsick TA, Yeatts SD, Liebeskind DS, Carrozzella J, Foster L, Goyal M, von Kummer R, Hill MD, Demchuk AM, Jovin T, Yan B, Zaidat OO, Schonewille W, Engelter S, Martin R, Khatri P, Spilker J, Palesch YY, Broderick JP; IMS III Investigators.

J Neurointerv Surg. 2015 Nov;7(11):795-802. doi: 10.1136/neurintsurg-2014-011318. Epub 2014 Oct 23.

PMID:
25342652
19.

Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials.

Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Mazighi M, Schonewille WJ, Engelter ST, Anderson C, Spilker J, Carrozzella J, Janis LS, Foster LD, Tomsick TA; Interventional Management of Stroke III Investigators.

Stroke. 2014 Dec;45(12):3606-11. doi: 10.1161/STROKEAHA.114.005952. Epub 2014 Oct 16.

20.

Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies.

Rahme R, Yeatts SD, Abruzzo TA, Jimenez L, Fan L, Tomsick TA, Ringer AJ, Furlan AJ, Broderick JP, Khatri P.

J Neurosurg. 2014 Dec;121(6):1354-8. doi: 10.3171/2014.7.JNS131430. Epub 2014 Sep 26.

PMID:
25259569
21.

Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial.

Demchuk AM, Goyal M, Yeatts SD, Carrozzella J, Foster LD, Qazi E, Hill MD, Jovin TG, Ribo M, Yan B, Zaidat OO, Frei D, von Kummer R, Cockroft KM, Khatri P, Liebeskind DS, Tomsick TA, Palesch YY, Broderick JP; IMS III Investigators.

Radiology. 2014 Oct;273(1):202-10. doi: 10.1148/radiol.14132649. Epub 2014 Jun 5.

22.

Capillary Index Score in the Interventional Management of Stroke trials I and II.

Al-Ali F, Tomsick TA, Connors JJ 3rd, Gebel JM, Elias JJ, Markarian GZ, Al-Ali Z, Broderick JP.

Stroke. 2014 Jul;45(7):1999-2003. doi: 10.1161/STROKEAHA.114.005304. Epub 2014 May 22.

23.

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial.

Khatri P, Yeatts SD, Mazighi M, Broderick JP, Liebeskind DS, Demchuk AM, Amarenco P, Carrozzella J, Spilker J, Foster LD, Goyal M, Hill MD, Palesch YY, Jauch EC, Haley EC, Vagal A, Tomsick TA; IMS III Trialists.

Lancet Neurol. 2014 Jun;13(6):567-74. doi: 10.1016/S1474-4422(14)70066-3. Epub 2014 Apr 27.

24.

Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial.

Liebeskind DS, Tomsick TA, Foster LD, Yeatts SD, Carrozzella J, Demchuk AM, Jovin TG, Khatri P, von Kummer R, Sugg RM, Zaidat OO, Hussain SI, Goyal M, Menon BK, Al Ali F, Yan B, Palesch YY, Broderick JP; IMS III Investigators.

Stroke. 2014 Mar;45(3):759-64. doi: 10.1161/STROKEAHA.113.004072. Epub 2014 Jan 28.

25.

Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial.

Hill MD, Demchuk AM, Goyal M, Jovin TG, Foster LD, Tomsick TA, von Kummer R, Yeatts SD, Palesch YY, Broderick JP; IMS3 Investigators.

Stroke. 2014 Feb;45(2):444-9. doi: 10.1161/STROKEAHA.113.003580. Epub 2013 Dec 12.

26.

Tribulations of stroke trials.

Broderick J, Tomsick TA; IMS III investigators.

J Neurointerv Surg. 2016 Jun;8(e1):e12-3. doi: 10.1136/neurintsurg-2013-010974. Epub 2013 Oct 14. No abstract available.

PMID:
24126639
27.

Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.

Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, Marks MP, Prabhakaran S, Kallmes DF, Fitzsimmons BF, Mocco J, Wardlaw JM, Barnwell SL, Jovin TG, Linfante I, Siddiqui AH, Alexander MJ, Hirsch JA, Wintermark M, Albers G, Woo HH, Heck DV, Lev M, Aviv R, Hacke W, Warach S, Broderick J, Derdeyn CP, Furlan A, Nogueira RG, Yavagal DR, Goyal M, Demchuk AM, Bendszus M, Liebeskind DS; Cerebral Angiographic Revascularization Grading (CARG) Collaborators; STIR Revascularization working group; STIR Thrombolysis in Cerebral Infarction (TICI) Task Force.

Stroke. 2013 Sep;44(9):2650-63. doi: 10.1161/STROKEAHA.113.001972. Epub 2013 Aug 6. No abstract available.

28.

Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.

Pancioli AM, Adeoye O, Schmit PA, Khoury J, Levine SR, Tomsick TA, Sucharew H, Brooks CE, Crocco TJ, Gutmann L, Hemmen TM, Kasner SE, Kleindorfer D, Knight WA, Martini S, McKinney JS, Meurer WJ, Meyer BC, Schneider A, Scott PA, Starkman S, Warach S, Broderick JP; CLEAR-ER Investigators.

Stroke. 2013 Sep;44(9):2381-7. doi: 10.1161/STROKEAHA.113.001059. Epub 2013 Jul 25.

29.

Endovascular treatment for acute ischemic stroke.

Broderick JP, Tomsick TA, Palesch YY.

N Engl J Med. 2013 Jun 20;368(25):2432-3. doi: 10.1056/NEJMc1304759. No abstract available.

PMID:
23782182
30.

Reimbursement for thrombectomy devices in patients who are ineligible for intravenous tissue-type plasminogen activator.

Broderick JP, Tomsick TA; Interventional Management of Stroke (IMS) III Executive Committee.

Stroke. 2013 May;44(5):1215-6. doi: 10.1161/STROKEAHA.113.001442. Epub 2013 Apr 18. No abstract available.

PMID:
23598521
31.

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.

Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, Zaidat OO, Malisch TW, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Martin RH, Foster LD, Tomsick TA; Interventional Management of Stroke (IMS) III Investigators.

N Engl J Med. 2013 Mar 7;368(10):893-903. doi: 10.1056/NEJMoa1214300. Epub 2013 Feb 7. Erratum in: N Engl J Med. 2013 Mar 28;368(13):1265.

32.

Is intra-arterial thrombolysis beneficial for M2 occlusions? Subgroup analysis of the PROACT-II trial.

Rahme R, Abruzzo TA, Martin RH, Tomsick TA, Ringer AJ, Furlan AJ, Carrozzella JA, Khatri P.

Stroke. 2013 Jan;44(1):240-2. doi: 10.1161/STROKEAHA.112.671495. Epub 2012 Dec 6.

33.

Performance and training standards for endovascular acute ischemic stroke treatment.

Meyers PM, Schumacher HC, Alexander MJ, Derdeyn CP, Furlan AJ, Higashida RT, Moran CJ, Tarr RW, Heck DV, Hirsch JA, Jensen ME, Linfante I, McDougall CG, Nesbit GM, Rasmussen PA, Tomsick TA, Wechsler LR, Wilson JR, Zaidat OO.

Neurology. 2012 Sep 25;79(13 Suppl 1):S234-8. Review.

PMID:
23008404
34.

Letter by Hill et al regarding article, "A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke".

Hill MD, Khatri P, Tomsick TA, Simpson KN, Broderick JP.

Stroke. 2011 Dec;42(12):e641-2; author reply e643. doi: 10.1161/STROKEAHA.111.637603. Epub 2011 Oct 27. No abstract available.

PMID:
22033994
35.

Intra-arterial iodinated radiographic contrast material injection administration in a rat middle cerebral artery occlusion and reperfusion model: possible effects on intracerebral hemorrhage.

Kurosawa Y, Lu A, Khatri P, Carrozzella JA, Clark JF, Khoury J, Tomsick TA.

Stroke. 2010 May;41(5):1013-7. doi: 10.1161/STROKEAHA.110.578245. Epub 2010 Apr 1.

36.

Equipoise among recanalization strategies.

Tomsick TA, Khatri P, Jovin T, Demaerschalk B, Malisch T, Demchuk A, Hill MD, Jauch E, Spilker J, Broderick JP; IMS III Executive Committee.

Neurology. 2010 Mar 30;74(13):1069-76. doi: 10.1212/WNL.0b013e3181d76b8f. Review.

37.

Performance and training standards for endovascular ischemic stroke treatment.

Writing Group for the American Academy of Neurology; AANS/CNS Cerebrovascular Section; Society of NeuroInterventional Surgery; Society of Vascular & Interventional Neurology, Meyers PM, Schumacher HC, Alexander MJ, Derdeyn CP, Furlan AJ, Higashida RT, Moran CJ, Tarr RW, Heck DV, Hirsch JA, Jensen ME, Linfante I, McDougall CG, Nesbit GM, Rasmussen PA, Tomsick TA, Wechsler LR, Wilson JR, Zaidat OO.

AJNR Am J Neuroradiol. 2010 Jan;31(1):E8-11.

38.

Performance and training standards for endovascular ischemic stroke treatment.

Meyers PM, Schumacher HC, Alexander MJ, Derdeyn CP, Furlan AJ, Higashida RT, Moran CJ, Tarr RW, Heck DV, Hirsch JA, Jensen ME, Linfante I, McDougall CG, Nesbit GM, Rasmussen PA, Tomsick TA, Wechsler LR, Wilson JA, Zaidat OO; American Academy of Neurology; AANS/CNS Cerebrovascular Section; Society of NeuroInterventional Surgery; Society of Vascular & Interventional Neurology.

J Neurosurg. 2010 Jul;113(1):149-52. doi: 10.3171/2009.12.JNS091813.

PMID:
20035576
39.

Performance and training standards for endovascular ischemic stroke treatment.

Meyers PM, Schumacher HC, Alexander MJ, Derdeyn CP, Furlan AJ, Higashida RT, Moran CJ, Tarr RW, Heck DV, Hirsch JA, Jensen ME, Linfante I, McDougall CG, Nesbit GM, Rasmussen PA, Tomsick TA, Wechsler LR, Wilson JR, Zaidat OO; Wrting Group for American Academy of Neurology, American Association of Neurological Surgeons Cerebrovascular Section, Society of Neurointerventional Surgery and Society of Vascular and Interventional Neurology.

J Stroke Cerebrovasc Dis. 2009 Nov-Dec;18(6):411-5. doi: 10.1016/j.jstrokecerebrovasdis.2009.08.001.

PMID:
19900641
40.

Good clinical outcome after ischemic stroke with successful revascularization is time-dependent.

Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA; IMS I and II Investigators.

Neurology. 2009 Sep 29;73(13):1066-72. doi: 10.1212/WNL.0b013e3181b9c847.

41.

Performance and training standards for endovascular ischemic stroke treatment.

Writing Group for the American Academy of Neurology, AANS/CNS Cerebrovascular Section, Society of NeuroInterventional Surgery, and the Society of Vascular & Interventional Neurology, Meyers PM, Schumacher HC, Alexander MJ, Derdeyn CP, Furlan AJ, Higashida RT, Moran CJ, Tarr RW, Heck DV, Hirsch JA, Jensen ME, Linfante I, McDougall CG, Nesbit GM, Rasmussen PA, Tomsick TA, Wechsler LR, Wilson JA, Zaidat OO.

J Neurointerv Surg. 2009 Jul;1(1):10-2. doi: 10.1136/jnis.2009.000687. Erratum in: J Neurointerv Surg. 2009 Dec;1(2):153. Wilson, J R [corrected to Wilson, J A].

PMID:
21994099
42.

Microcatheter contrast injections during intra-arterial thrombolysis may increase intracranial hemorrhage risk.

Khatri P, Broderick JP, Khoury JC, Carrozzella JA, Tomsick TA; IMS I and II Investigators.

Stroke. 2008 Dec;39(12):3283-7. doi: 10.1161/STROKEAHA.108.522904. Epub 2008 Sep 4.

43.

Methodology of the Interventional Management of Stroke III Trial.

Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, Demchuk AM, Martin R, Mauldin P, Dillon C, Ryckborst KJ, Janis S, Tomsick TA, Broderick JP; Interventional Management of Stroke III Investigators.

Int J Stroke. 2008 May;3(2):130-7. doi: 10.1111/j.1747-4949.2008.00151.x.

44.

Direct ascending pharyngeal artery to jugular vein arteriovenous fistula. A case report.

Tomsick SD, Tomsick TA.

Interv Neuroradiol. 2008 Jun 30;14(2):191-4. Epub 2008 Jun 30.

45.

Brain parenchymal signal abnormalities associated with developmental venous anomalies: detailed MR imaging assessment.

Santucci GM, Leach JL, Ying J, Leach SD, Tomsick TA.

AJNR Am J Neuroradiol. 2008 Aug;29(7):1317-23. doi: 10.3174/ajnr.A1090. Epub 2008 Apr 16.

46.

Large arachnoid granulations involving the dorsal superior sagittal sinus: findings on MR imaging and MR venography.

Leach JL, Meyer K, Jones BV, Tomsick TA.

AJNR Am J Neuroradiol. 2008 Aug;29(7):1335-9. doi: 10.3174/ajnr.A1093. Epub 2008 Apr 16. Review.

47.

Eye position information on CT increases the identification of acute ischemic hypoattenuation.

Mahajan V, Minshew PT, Khoury J, Shu PP, Muzaffar M, Abruzzo T, Leach JL, Tomsick TA.

AJNR Am J Neuroradiol. 2008 Jun;29(6):1144-6. doi: 10.3174/ajnr.A0995. Epub 2008 Mar 20.

48.

Embolization of calcific thrombi after tissue plasminogen activator treatment.

Kissela BM, Kothari RU, Tomsick TA, Woo D, Broderick J.

J Stroke Cerebrovasc Dis. 2001 May-Jun;10(3):135-8.

PMID:
17903815
49.
50.

A multidisciplinary approach to carotid paragangliomas.

Kasper GC, Welling RE, Wladis AR, CaJacob DE, Grisham AD, Tomsick TA, Gluckman JL, Muck PE.

Vasc Endovascular Surg. 2006 Dec-2007 Jan;40(6):467-74.

PMID:
17202093

Supplemental Content

Loading ...
Support Center